These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19004008)

  • 1. Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer.
    Révillion F; Puech C; Rabenoelina F; Chalbos D; Peyrat JP; Freiss G
    Int J Cancer; 2009 Feb; 124(3):638-43. PubMed ID: 19004008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.
    Glondu-Lassis M; Dromard M; Lacroix-Triki M; Nirdé P; Puech C; Knani D; Chalbos D; Freiss G
    Cancer Res; 2010 Jun; 70(12):5116-26. PubMed ID: 20501847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay.
    Pawlowski V; Révillion F; Hebbar M; Hornez L; Peyrat JP
    Clin Cancer Res; 2000 Nov; 6(11):4217-25. PubMed ID: 11106235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation.
    Dromard M; Bompard G; Glondu-Lassis M; Puech C; Chalbos D; Freiss G
    Cancer Res; 2007 Jul; 67(14):6806-13. PubMed ID: 17638892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.
    Tong D; Schneeberger C; Czerwenka K; Schmutzler RK; Speiser P; Kucera E; Concin N; Kubista E; Leodolter S; Zeillinger R
    Clin Cancer Res; 1999 Jun; 5(6):1497-502. PubMed ID: 10389938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN13/PTPL1: an important regulator of tumor aggressiveness.
    Freiss G; Chalbos D
    Anticancer Agents Med Chem; 2011 Jan; 11(1):78-88. PubMed ID: 21235435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTPL1: a large phosphatase with a split personality.
    Abaan OD; Toretsky JA
    Cancer Metastasis Rev; 2008 Jun; 27(2):205-14. PubMed ID: 18265946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
    Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Kawaguchi M; Miura Y; Iwase H
    Clin Cancer Res; 2005 Jan; 11(1):193-8. PubMed ID: 15671546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer.
    Reimer T; Koczan D; Müller H; Friese K; Thiesen HJ; Gerber B
    Breast Cancer Res; 2002; 4(5):R9. PubMed ID: 12223126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells.
    Bompard G; Puech C; Prébois C; Vignon F; Freiss G
    J Biol Chem; 2002 Dec; 277(49):47861-9. PubMed ID: 12354757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer.
    Yousef GM; Scorilas A; Nakamura T; Ellatif MA; Ponzone R; Biglia N; Maggiorotto F; Roagna R; Sismondi P; Diamandis EP
    Breast Cancer Res Treat; 2003 Mar; 78(2):149-58. PubMed ID: 12725415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
    Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PTPL1, a proapoptotic protein tyrosine phosphatase in breast cancers].
    Freiss G; Bompard G; Vignon F
    Bull Cancer; 2004 Apr; 91(4):325-32. PubMed ID: 15242314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of ERM gene expression in human primary breast cancers.
    Chotteau-Lelièvre A; Révillion F; Lhotellier V; Hornez L; Desbiens X; Cabaret V; de Launoit Y; Peyrat JP
    Clin Cancer Res; 2004 Nov; 10(21):7297-303. PubMed ID: 15534105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival.
    Li J; Zhang N; Song LB; Liao WT; Jiang LL; Gong LY; Wu J; Yuan J; Zhang HZ; Zeng MS; Li M
    Clin Cancer Res; 2008 Jun; 14(11):3319-26. PubMed ID: 18519759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and Significance of PTPL1 in Hematological Malignancies].
    Wang WM; Wang J; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1744-7. PubMed ID: 25543508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
    Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
    Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
    Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.